Table 1.
Cohort characteristics and screening results for the 274 samples included in the current study
| Total Cohort (N = 274) | |
|---|---|
| Nationality | |
| Norwegian | 82 |
| Australian | 192 |
| Female | 183 |
| Male | 91 |
| Median age at first cancera | 51.5 [21–86] |
| Cancer historyb | |
| CRC | 229 |
| Other cancers | 28 |
| Only adenomas | 14 |
| Multiple primary cancers | 64 |
| Amsterdam Criteria II | |
| Positive | 262 |
| Negativec | 12 |
| Microsatellite instability statusd | |
| MSS | 38 |
| MSI‐L | 6 |
| MSI‐H | 27 |
| IHCe | |
| Loss of MMR protein staining | 83 |
| Normal staining | 56 |
a
Data missing for six patients.
b
Data missing for three patients.
c
Revised Bethesda Guidelines (BG) positive.
d
Only available for the Norwegian patients. Data missing for 203 patients.
e
Data available for 68 Norwegian and 71 Australian samples. Data missing for 135 patients.